ESTA icon

Establishment Labs

36.84 USD
-0.63
1.68%
At close Updated Sep 15, 4:00 PM EDT
Pre-market
After hours
36.84
0.00
0%
1 day
-1.68%
5 days
-2.72%
1 month
-3.86%
3 months
-5.32%
6 months
-6.19%
Year to date
-18.64%
1 year
-17.51%
5 years
96.9%
10 years
48.85%
 

About: Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.

Employees: 1,056

0
Funds holding %
of 7,463 funds
0
Analysts bullish %
of 3 analysts

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

96% more repeat investments, than reductions

Existing positions increased: 55 | Existing positions reduced: 28

30% more call options, than puts

Call options by funds: $5.34M | Put options by funds: $4.1M

14% more first-time investments, than exits

New positions opened: 24 | Existing positions closed: 21

5% more capital invested

Capital invested by funds: $1.08B [Q1] → $1.13B (+$49M) [Q2]

1% more funds holding

Funds holding: 136 [Q1] → 137 (+1) [Q2]

0.11% less ownership

Funds ownership: 91.59% [Q1] → 91.49% (-0.11%) [Q2]

11% less funds holding in top 10

Funds holding in top 10: 9 [Q1] → 8 (-1) [Q2]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$47
28% upside
Avg. target
$59
60% upside
High target
$70
90% upside

3 analyst ratings

positive
67%
neutral
33%
negative
0%
Canaccord Genuity
Caitlin Cronin
$60
Buy
Initiated
20 Aug 2025
Mizuho
Anthony Petrone
$70
Outperform
Maintained
16 Jul 2025
Citigroup
Joanne Wuensch
$47
Neutral
Maintained
9 Jul 2025

Financial journalist opinion

Neutral
Seeking Alpha
1 month ago
Establishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call Transcript
Establishment Labs Holdings Inc. (NASDAQ:ESTA ) Q2 2025 Earnings Conference Call August 7, 2025 8:30 AM ET Company Participants Fillipo Peter Caldini - CEO & Director Rajbir Singh Denhoy - Chief Financial Officer Conference Call Participants Anthony Charles Petrone - Mizuho Americas LLC Joshua Thomas Jennings - TD Cowen, Research Division K. Gong - JPMorgan Chase & Co, Research Division Mason Owen Carrico - Stephens Inc., Research Division Matthew Charles Taylor - UBS Investment Bank, Research Division Mike Matson - Unidentified Company Sam Shimon Eiber - BTIG, LLC, Research Division Operator Good morning.
Establishment Labs Holdings Inc. (ESTA) Q2 2025 Earnings Call Transcript
Negative
Zacks Investment Research
1 month ago
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Misses Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.57 per share versus the Zacks Consensus Estimate of a loss of $0.54. This compares to a loss of $0.62 per share a year ago.
Establishment Labs Holdings Inc. (ESTA) Reports Q2 Loss, Misses Revenue Estimates
Neutral
Business Wire
1 month ago
Establishment Labs Reports Second Quarter 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the second quarter ended June 30, 2025. Second Quarter Highlights and Outlook (Unaudited) Second quarter worldwide revenue of $51.3 million, an increase of 16.3% from the year ago period. Revenue included $10.3 million of Motiva sales in the Un.
Establishment Labs Reports Second Quarter 2025 Financial Results
Neutral
Business Wire
1 month ago
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, plans to announce its financial results for the quarter ended June 30, 2025, before the market opens on Thursday, August 7, 2025, and will host a conference call at 8:30 am ET that day to discuss those results. To participate in the conference call, dial (416) 764 8646 (U.S. and Ca.
Establishment Labs to Announce Second Quarter 2025 Financial Results on August 7
Neutral
Business Wire
3 months ago
Establishment Labs Hosting Investor Day on June 12
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, will host its previously announced analyst and investor event in New York City on June 12, 2025 beginning at 1pm ET. A live and archived webcast of presentations and Q&A sessions on June 12 will be available on the "Investors" section of the Establishment Labs website at www.es.
Establishment Labs Hosting Investor Day on June 12
Neutral
Business Wire
3 months ago
Establishment Labs to Present at Jefferies Global Healthcare Conference
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced its participation in the Jefferies Global Healthcare Conference. Peter Caldini, Chief Executive Officer, and Raj Denhoy, Chief Financial Officer, are scheduled to present in a fireside chat on Wednesday, June 4, 2025 at 7:35 a.m. ET. A live webcast of the presentati.
Establishment Labs to Present at Jefferies Global Healthcare Conference
Neutral
Seeking Alpha
4 months ago
Establishment Labs Holdings, Inc. (ESTA) Q1 2025 Earnings Call Transcript
Establishment Labs Holdings, Inc. (NASDAQ:ESTA ) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ET Company Participants Peter Caldini - Chief Executive Officer Rajbir Denhoy - Chief Financial Officer Juan Jose Chacon-Quiros - Former CEO & Founder Conference Call Participants Marie Thibault - BTIG Joshua Jennings - TD Cowen Michael Matson - Needham & Company Allen Gong - JPMorgan Mason Carrico - Stephens Joanne Wuensch - Citibank Matthew Taylor - Jefferies Anthony Petrone - Mizuho Group Operator Good afternoon, and welcome to the Establishment Labs First Quarter 2025 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Establishment Labs Holdings, Inc. (ESTA) Q1 2025 Earnings Call Transcript
Negative
Zacks Investment Research
4 months ago
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates
Establishment Labs Holdings Inc. (ESTA) came out with a quarterly loss of $0.70 per share versus the Zacks Consensus Estimate of a loss of $0.83. This compares to loss of $0.58 per share a year ago.
Establishment Labs Holdings Inc. (ESTA) Reports Q1 Loss, Lags Revenue Estimates
Neutral
Business Wire
4 months ago
Establishment Labs Reports First Quarter 2025 Financial Results
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, today announced financial results for the first quarter ended March 31, 2025. First Quarter Highlights and Outlook First quarter worldwide revenue of $41.4 million, including $6.2 million of Motiva sales in the United States. 2025 revenue guidance maintained at $205 million to $210.
Establishment Labs Reports First Quarter 2025 Financial Results
Neutral
Business Wire
4 months ago
Establishment Labs Appoints Peter Caldini as Chief Executive Officer
NEW YORK--(BUSINESS WIRE)--Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women's health and wellness, principally in breast aesthetics and reconstruction, announced today the appointment of Peter Caldini as Chief Executive Officer effective May 7, 2025. Mr. Caldini has served as Interim CEO since March 1, 2025, when Establishment Labs' Founder and previous CEO Juan José Chacón-Quirós retired from the role. “After an extensive search.
Establishment Labs Appoints Peter Caldini as Chief Executive Officer
Charts implemented using Lightweight Charts™